Midazolam Hydrochloride Flashcards
(24 cards)
Drug classification (2)
- Anticonvulsant
2. Sedative/hypnotic (a benzodiazepine)
Trade name (2)
Versed
Hypnovel
Actions (3)
- Depresses the central nervous system
- Relaxes skeletal muscle
- Decreases patient recall (amnesic effect in intubation or cardioversion)
Indications (5)
- Suppression of seizure activity
- Sedation prior to cardioversion or TC pacing
- Facilitate intubation
- Agitated delirium
- Prevent/suppress seizure caused by organophosphate (nerve agent) poisoning
Contraindication (4)
- Infants less than 6 months old
- Shock/hypotension
- Glaucoma
- Patients known to be taking
- calcium channel blockers
- AIDS medication
- Anti-Fungal medications
Relative Contraindication (2)
- Head injury
2. Alcohol intoxication/Narcotic Ingestion
Adverse effects - cardiovascular (4)
Bradycardia
Tachycardia*
Hypotension*
PVCs*
Adverse effects - Respiratory (5)
Cough/Dyspnea Depression, apnea* Laryngospasm* Bronchospasm* Respiratory arrest*
Adverse effects - Neurological (5)
- Drowsiness*
- Amnesia*, confusion
- Blurred vision*
- Headache
- Restlessness
Adverse effects - Gastrointestinal (3)
Nausea/vomiting
Hiccups
Increased salivation
Adverse effects - general (2)
Pain during injection
Phlebitis
Administration - sedation for Cardioversion or TCP
1-2 mg SLOW IVP at 1mg/min. Titrate to produce sedation
2.5 mg IM or IN
Max total dose is 10 mg
Administration - seizures
2-5 mg SLOW IVP at 1mg/min. Titrate ti suppress seizure activity.
May repeat IVP every 3-5min. PRN.
5 mg IM or IN. May repeat IM or IN dose one time in 5 min.
Maximum total dose 10 mg.
Administration - Agitated Delirium
2-5 mg SLOW IVP at 1mg/min. Titrate until sedation occurs.
5 mg IM or IN. May repeat IM or IN dose one time.
Maximum total dose is 10 mg.
Pediatrics - seizures
0.1 mg/kg SLOW IVP at 1 mg/min. Titrate IV dose to suppress seizure activity.
Or 0.1 mg/kg IM or IN. May repeat IVP/IM/IN dose one time PRN
Maximum total dose is 5 mg
Pediatrics - sedation for Cardioversion
0.1 mg/kg SLOW IVP at 1 mg/min or 0.1 mg/kg IM or IN
Titrate IV dose to produce sedation. May repeat IVP/IM/IN dose every 3-5 minutes
Maximum total dose 5 mg.
Onset
IVP = 1-5 minutes IM = 10-15 minutes IN = 10 minutes
Duration
2-4 hours
Precaution
Monitor respiratory and cardiac status and prepare to support airway, ventilation, and circulation PRN
Rationale
Midazolam is 3-4 times more potent than diazepam (3mg midazolam = 10 mg diazepam)
Precaution
Monitor respiratory status and prepare to support airway and ventilation. BVM and OP airway should be immediately available.
Rationale
There is a significant risk of respiratory depression or arrest and airway obstruction due to laryngeal and bronchial spasm, especially in COPD patients.
Precaution
Continuous pulse oximetry
Rationale
Monitor for hypoventilation
Precaution
Administer only one-half the recommended dose to debilitated patients and patients > 60 years of age
Rationale
Decreased hepatic metabolism prolongs the sedative effects in patients with liver or kidney disease and patients taking AIDS medication
Note
The contraindication listed for Relative only in the event of seizure activity in the prehospital setting. However, these contraindications should be seriously considered when midazolam is to be given for sedation.
Action of midazolam is potentials when patients are taking verapamil, diltiazem, effects may result in potentially life-threatening respiratory depression or dysrhythmias
Antidote to reverse respiratory depression is Romazicon (flumazenil)
There is an increased risk of digoxin toxicity because of hypokalemia
Pediatrics oatients may require higher doses than adults, and children less than 6 years of age require higher doses than the 6-12 year age group
Infants less than 6 months of age are unable to metabolize midazolam due to liver immaturity and may experience severe respiratory depression
Midazolam is a Schedule IV medication and will have additional storage and record-keeping requirements
How supplied
1 mg/mL and 5 mg/ml preparation
1 mg/mL preparation = 0.1 mg/0.1 mL
5 mg/mL preparation = 0.5 mg/0.1 mL